Product profiles
Please select the links below for a description of each of Vectura’s marketed products.
-
Asmasal® and Asmabec® -
Asmasal® and Asmabec® are Clickhaler®-based products; Asmasal® contains salbutamol, a short-acting beta-2 agonist for the quick relief of asthma symptoms, and Asmabec® contains beclometasone, an inhaled steroid used as standard preventative therapy for asthma. Asmasal® and Asmabec® are marketed by UCB in UK, France and Ireland.
Close -
Budesonide Clickhaler® and Formoterol Clickhaler® -
These are Clickhaler®-based products containing budesonide and formoterol. Budesonide is a steroid used as standard preventative therapy for asthma and formoterol is a long-acting beta-2 agonist with a fast onset of action and longer duration than salbutamol, benefiting patients with more severe symptoms. Both products are marketed by Merck Generics (part of Mylan Inc) in certain European countries and South Africa (formoterol only). Further European approvals are being progressed.
Close -
Meptin® Clickhaler® -
Otsuka in Japan has licensed the Clickhaler® technology from Vectura. The device is used to deliver its short-acting beta-2 agonist Meptin® (procaterol) for the quick relief of mild, intermittent asthma symptoms.
Close -
Adept® -
Adept® is a 4% icodextrin solution used during surgery to prevent post-surgical adhesions; a frequent complication following gynaecological and other abdominal surgery and which is acknowledged as a major surgical problem. Adept® was licensed in a global deal with Baxter in 2006 and is now available in more than 20 countries worldwide including the key European and United States markets.
Close -
Extraneal® -
Extraneal® is a peritoneal dialysis solution containing icodextrin, used for the management of renal failure patients. Extraneal® is licensed to Baxter worldwide and marketed in more than 45 countries.
Close -
ADVATE® -
ADVATE® is a serum-free formulation of Factor VIII, a complex protein which aids blood clotting, used in the treatment of haemophilia A. It was developed by Baxter using Vectura’s intellectual property and is now marketed worldwide by Baxter.
Close
